Ticker Symbol: ABOS
Acumen Pharmaceuticals Inc
$10.73 - 04-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001576885
Company Profile
acumen is forging a new path towards safe and effective treatments for alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers. our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (aβo) in synaptic dysfunction and neurodegeneration. these early insights have fostered decades of research on the biology of aβo at acumen and throughout the field. we are now on the on cusp of realizing the therapeutic potential of aβo targeted drugs.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: acumenpharm.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $3.46
Change:
-$0.03
(
-0.86%)
Days Range: $3.39 - $3.62
Beta: 1.11
52wk. High: $11.31
52wk. Low: $3.41
Ytd. Change -36.79%
50 Day Moving Average: $4.67
200 Day Moving Average: $5.35
Shares Outstanding: 57868512
Valuation
Market Cap: 20.0B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A